Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Other Expenses (Details)

v3.22.0.1
Other Expenses (Details)
12 Months Ended
Aug. 16, 2019
CAD ($)
Dec. 31, 2021
CAD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
CAD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
CAD ($)
Dec. 31, 2019
USD ($)
Other Expenses And Adjustments [Line Items]              
Share-based compensation   $ 3,825,901   $ 2,558,974   $ 1,470,153  
Depreciation - right-of-use assets   321,822   357,230      
Transaction cost, warrant derivative   1,256,280   1,741,640   854,256  
Shares Under Warrant Derivative Agreement              
Other Expenses And Adjustments [Line Items]              
Transaction cost, warrant derivative $ 699,427            
Included in research and development expenses:              
Other Expenses And Adjustments [Line Items]              
Employee compensation and benefits   4,645,264   3,775,263   3,096,231  
Share-based compensation   2,086,608   1,043,373   561,420  
Included in operating expenses              
Other Expenses And Adjustments [Line Items]              
Employee compensation and benefits   2,542,210   2,635,170   2,555,274  
Share-based compensation   1,739,293   1,515,601   908,733  
Depreciation - property and equipment   130,243   88,957   122,982  
Depreciation - right-of-use assets     $ 321,822   $ 357,230   $ 362,592
Included in operating expenses | Shares Under Warrant Derivative Agreement              
Other Expenses And Adjustments [Line Items]              
Transaction cost, warrant derivative $ 233,143 $ 0   $ 0   $ 233,143